tiprankstipranks
Spyre Therapeutics, Inc (SYRE)
NASDAQ:SYRE
US Market
Want to see SYRE full AI Analyst Report?

Spyre Therapeutics (SYRE) Technical Analysis

572 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Spyre Therapeutics, Inc’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is 3.49, suggesting Spyre Therapeutics, Inc is a Buy.
Spyre Therapeutics, Inc’s (SYRE) 20-Day exponential moving average is 99.98, while Spyre Therapeutics, Inc’s (SYRE) share price is $102.13, making it a Buy.
Spyre Therapeutics, Inc’s (SYRE) 50-Day exponential moving average is 91.81, while Spyre Therapeutics, Inc’s (SYRE) share price is $102.13, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Aug 11, 2026, 03:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
100.45
102.04
103.48
105.07
106.51
108.10
109.54
Fibonacci
102.04
103.20
103.92
105.07
106.23
106.95
108.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Aug 11, 2026, 03:13 PM
Period
Simple
Exponential
MA5
104.59Buy
103.86Buy
MA10
101.55Buy
102.40Buy
MA20
100.61Buy
99.98Buy
MA50
91.24Buy
91.81Buy
MA100
77.29Buy
79.08Buy
MA200
54.80Buy
58.46Buy
Spyre Therapeutics, Inc’s (SYRE) 10-Day exponential moving average is 102.40, while Spyre Therapeutics, Inc’s (SYRE) share price is $102.13, making it a Buy.
Spyre Therapeutics, Inc’s (SYRE) 100-Day exponential moving average is 79.08, while Spyre Therapeutics, Inc’s (SYRE) share price is $102.13, making it a Buy.
Spyre Therapeutics, Inc’s (SYRE) stock price is $102.13 and Spyre Therapeutics, Inc’s (SYRE) 50-day simple moving average is 91.24, creating a Buy signal.
Spyre Therapeutics, Inc’s (SYRE) stock price is $102.13 and Spyre Therapeutics, Inc’s (SYRE) 100-day simple moving average is 77.29, creating a Buy signal.
Spyre Therapeutics, Inc’s (SYRE) stock price is $102.13 and Spyre Therapeutics, Inc’s (SYRE) 200-day simple moving average is 54.80, creating a Buy signal.

Spyre Therapeutics (SYRE) Technical Indicators

Aug 11, 2026, 03:13 PM
Name
Value
Implied Action
RSI (14)
59.65
Neutral
STOCH (9,6)
77.13
Neutral
STOCHRSI (14)
77.26
Neutral
MACD (12,26)
3.49
Buy
ADX (14)
19.90
Buy
Williams %R
-17.82
Sell
CCI (14)
144.69
Sell
ATR (14)
5.94
-
Ultimate Oscillator
57.18
Neutral
ROC
2.56
Buy
Spyre Therapeutics, Inc’s (SYRE) Relative Strength Index (RSI) is 59.65, creating a Neutral signal.
Spyre Therapeutics, Inc’s (SYRE) Trend Strength Indicator (ADX) is 19.90, creating a Buy signal.
Spyre Therapeutics, Inc’s (SYRE) Commodity Channel Index (CCI) is 144.69, creating a Sell signal.
Spyre Therapeutics, Inc’s (SYRE) Price Rate of Change (ROC) is 2.56, creating a Buy signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Strong Buy.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 59.65, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is 3.49, which suggests SYRE is a Buy.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 104.59, which suggests SYRE is a Buy.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 100.61, which suggests SYRE is a Buy.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 91.24, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 54.80, which suggests SYRE is a Buy.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -17.82, which suggests SYRE is a Sell.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is 144.69, which suggests SYRE is a Sell.